hVIVO plc (LON:HVO – Get Free Report) shot up 10% during trading on Monday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). 7,804,669 shares were traded during mid-day trading, an increase of 164% from the average session volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Up 10.0 %
The company has a market capitalization of £144.58 million, a P/E ratio of 708.33 and a beta of 0.97. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The stock’s fifty day moving average is GBX 20.25 and its 200 day moving average is GBX 25.68.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- Best Stocks Under $5.00
- Sizing Up a New Opportunity for NVIDIA Investors
- What is the Dow Jones Industrial Average (DJIA)?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- The Significance of Brokerage Rankings in Stock Selection
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
